Roswell Park Clinical Trial Points Toward Promising New Therapy for Most Aggressive Type of Breast Cancer

High rate of complete remission achieved without immune-related adverse side effects in patients with TNBC Triple-negative breast cancer accounts for 10-20% of all breast cancers Study assessed a new pre-surgery immunotherapy/chemotherapy combination Findings appear in Journal for...